Atlas Bio uses AI to simulate clinical trials and drug behaviour, in order to replace part of phase II trials and animal testing. This USD 10 million seed round comes on top of a USD 2.5 million pre-seed round led by First Momentum Ventures and LEA Partners.
- Announced on
- Round
- Seed
- Amount
- USD 10 M
- Location
- Basel, canton of Basel-Stadt
- Sector
- Biotech & life sciences
Investors
- Creandum lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic